Does RISANKIZUMAB-RZAA Cause Sinus disorder? 127 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 127 reports of Sinus disorder have been filed in association with RISANKIZUMAB-RZAA. This represents 0.2% of all adverse event reports for RISANKIZUMAB-RZAA.
127
Reports of Sinus disorder with RISANKIZUMAB-RZAA
0.2%
of all RISANKIZUMAB-RZAA reports
0
Deaths
15
Hospitalizations
How Dangerous Is Sinus disorder From RISANKIZUMAB-RZAA?
Of the 127 reports, 15 (11.8%) required hospitalization.
Is Sinus disorder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 127 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Sinus disorder?
ADALIMUMAB (955)
ETANERCEPT (801)
DUPILUMAB (684)
LENALIDOMIDE (550)
TOFACITINIB (535)
PREDNISONE (519)
ALBUTEROL (491)
TREPROSTINIL (429)
HUMAN IMMUNOGLOBULIN G (398)
SECUKINUMAB (385)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Sinus disorder Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA